2007
DOI: 10.1039/b706677p
|View full text |Cite
|
Sign up to set email alerts
|

The third evolution of ionic liquids: active pharmaceutical ingredients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
650
0
12

Year Published

2007
2007
2018
2018

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 782 publications
(665 citation statements)
references
References 26 publications
3
650
0
12
Order By: Relevance
“…The first attempt to specifically prepare active pharmaceutical ionic liquids (API-ILs) was accomplished by Rogers and co-workers (Hough et al, 2007), who developed the potential scope of this poorly exploited drug phase. Since then, API-ILs have been studied by a number of groups.…”
Section: Introductionmentioning
confidence: 99%
“…The first attempt to specifically prepare active pharmaceutical ionic liquids (API-ILs) was accomplished by Rogers and co-workers (Hough et al, 2007), who developed the potential scope of this poorly exploited drug phase. Since then, API-ILs have been studied by a number of groups.…”
Section: Introductionmentioning
confidence: 99%
“…This dual functionality inherent in ILs is rarely exploited, 67,68 and we have only recently published our first paper with the designed incorporation of two biologically active ions into an IL. 69 Given that polymorphism and solvate formation cannot be predicted; that the exact crystalline state affects chemical (e.g., dissolution rate, solubility), biological (e.g., bioavailability, pharmacokinetics), mechanical, and physical properties, as well as, manufacturing processes; and that polymorphs and solvates may inconveniently interconvert-what are needed are chemical compositions that a) are effective for their intended purpose; b) have controlled and tunable chemical, biological, and physical properties, c) are in a form that is not subject to polymorphism, and d) for which controlled tunable dissolution and solubility are possible. In other words, ionic liquids.…”
Section: Ionic Liquids As Active Pharmaceutical Ingredients (Apis)mentioning
confidence: 99%
“…ILs have received considerable attention for a wide range of applications, across catalysis reactions, electrochemistry, separation science, polymer chemistry, formulation of pharmaceutical drugs, amongst others (81,82). The reader is invited to consult several reviews available in the literature to have a wider insight on this matter.…”
Section: Introduction To Ionic Liquidsmentioning
confidence: 99%